Please use this identifier to cite or link to this item:
Publication type: Article in scientific journal
Type of review: Peer review (publication)
Title: How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts
Authors: Wieser, Simon
Riguzzi, Marco
Pletscher, Mark
Huber, Carola A.
Telser, Harry
Schwenkglenks, Matthias
DOI: 10.21256/zhaw-3749
Published in: The European Journal of Health Economics
Volume(Issue): 19
Issue: 8
Page(s): 1
Pages to: 13
Issue Date: 2018
Publisher / Ed. Institution: Springer
ISSN: 1618-7601
Language: English
Subjects: Cost-of-illness; Decomposition by disease; Healthcare cost; Healthcare expenditure; National health account; Switzerland
Subject (DDC): 362.1041: Health economics
Abstract: In most countries, surprisingly little is known on how national healthcare spending is distributed across diseases. Single-disease cost-of-illness studies cover only a few of the diseases affecting a population and in some cases lead to untenably large estimates. The objective of this study was to decompose healthcare spending in 2011, according to Swiss National Health Accounts, into 21 collectively exhaustive and mutually exclusive major disease categories. Diseases were classified following the Global Burden of Disease Study. We first assigned the expenditures directly mapping from National Health Accounts to the 21 diseases. The remaining expenditures were assigned based on diagnostic codes and clues contained in a variety of microdata sources. Expenditures were dominated by non-communicable diseases with a share of 79.4%. Cardiovascular diseases stood out with 15.6% of total spending, followed by musculoskeletal disorders (13.4%), and mental and substance use disorders (10.6%). Neoplasms (6.0% of the total) ranked only sixth, although they are the leading cause of premature death in Switzerland. These results may be useful for the design of health policies, as they illustrate how healthcare spending is influenced by the epidemiological transition and increasing life expectancy. They also provide a plausibility check for single cost-of-illness studies. Our study may serve as a starting point for further research on the drivers of the constant growth of healthcare spending.
Fulltext version: Published version
License (according to publishing contract): CC BY 4.0: Attribution 4.0 International
Departement: School of Management and Law
Organisational Unit: Winterthur Institute of Health Economics (WIG)
Appears in collections:Publikationen School of Management and Law

Files in This Item:
File Description SizeFormat 
10.1007_s10198-018-0963-5.pdf1.2 MBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.